Patents Assigned to NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIG
  • Fasudil for the treatment of schizophrenia
    Patent number: 11478482
    Abstract: The present invention provides an antipsychotic drug comprising fasudil or a pharmaceutically acceptable salt thereof as an active agent for the treatment of schizophrenia, including schizophrenia caused by dysfunction of ARHGAP10.
    Type: Grant
    Filed: January 31, 2022
    Date of Patent: October 25, 2022
    Assignee: NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIG
    Inventors: Norio Ozaki, Kiyofumi Yamada, Taku Nagai, Daisuke Mori, Yuko Arioka, Itaru Kushima